Michael Edelstein on Muck Rack

Michael Edelstein

New South Wales
As seen in: Accountants EXPOSED (Podcast), Wiley Online Library, MDPI, Comingsoon.it, medRxiv, International Journal of Infectious Disease, Anchor.fm
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Rethinking under-vaccination: social identity and its association with vaccination attitudes and hesitancy-related behaviour

|
By Rotem Kahalon, Michael Edelstein, Leah Borovoi
| medRxiv
The authors have declared no competing interest. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (80) Issue with article?

The High Prevalence of Thyroid Goiter Between Arab Minorities in Israel - a Possible Hereditary Connection

|
By Adi Sharabi-Nov, Ekaterina Pundyk Babitzki, Raed Farhat, Michael Edelstein
| preprints.org
Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.
Open in Who Shared View Duplicates (7) Issue with article?

Gene therapy clinical trials worldwide to 2023-an update

|
By Samantha L. Ginn, Mawj Mandwie, Ian Alexander, Michael Edelstein
| Wiley Online Library
CONFLICT OF INTEREST STATEMENT ME and MRA receive payment from John Wiley and Sons Ltd for their work on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide database. SLG, MM and IEA declare that they have no conflicts of interest. REFERENCES 1 The U.S. Food and Drug Administration. Press Announcement 2017. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss.
Open in Who Shared Issue with article?
See all 20 licensed articles (22 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified